Inventor · disambiguated record
Ryan Hansen
Also filed as: HANSEN RYAN · HANSEN RYAN J · HANSEN RYAN JAMES
5 granted patents·8 pending applications·32 citations·filing 2004–2023
76Inventor score
Top patents by PatentIndex Score
13 records- 0191US11547711B2Replication stress pathway agent compositions and methods for treating cancerBOUNDLESS BIO INC·Filed 2022·Granted Jan 10, 2023·4 cites·14 claims
- 0289US11642345B2Replication stress pathway agent compositions and methods for treating cancerBOUNDLESS BIO INC·Filed 2022·Granted May 9, 2023·2 cites·7 claims
- 0388US7662928B2Anti-FcRn antibodies for treatment of auto/allo immune conditionsUNIV NEW YORK STATE RES FOUND·Filed 2006·Granted Feb 16, 2010·24 cites·13 claims
- 0476US12246017B2Replication stress pathway agent compositions and methods for treating cancerBOUNDLESS BIO INC·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 0574US11596637B2CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growthSIERRA ONCOLOGY INC·Filed 2018·Granted Mar 7, 2023·2 cites·21 claims
- 0660US2023272485A1Replication stress pathway agent compositions and methods for treating cancerBOUNDLESS BIO INC·Filed 2023·Application pending·0 cites
- 0745US2023078511A1Methods of using momelotinib to treat joint inflammationSIERRA ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0841US2020397796A1Methods of treatment of cancer comprising chk1 inhibitorsSIERRA ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 0941US2022226338A1Methods of Treating Cancer Using CHK1 InhibitorsSIERRA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1040US2005079169A1Anti-FcRn antibodies for treatment of auto/allo immune conditionsFiled 2004·Application pending·0 cites
- 1138US2013029862A1Clinical application utilizing genetic data for effective medication managementDAVIES GARETH·Filed 2012·Application pending·0 cites
- 1238US2022184091A1Methods of Treating Cancer with Chk1 InhibitorsSIERRA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1336US2020157638A1Biomarkers and patient selection strategiesSIERRA ONCOLOGY INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →